Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. TianYu Bio-Technology Co's Revenue for the
three
months ended in Jun. 2026 was ¥196.8 Mil. TianYu Bio-Technology Co's average Accounts Receivable for the
three
months ended in Jun. 2026 was ¥326.9 Mil.
Hence, TianYu Bio-Technology Co's Receivables Turnover for the
three
months ended in Jun. 2026 was 0.60.
TianYu Bio-Technology Co (SHSE:603717) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
TianYu Bio-Technology Co Receivables Turnover Related Terms
TianYu Bio-Technology Co Receivables Turnover Historical Data
* Premium members only.
The historical data trend for TianYu Bio-Technology Co's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TianYu Bio-Technology Co Receivables Turnover Chart
SHSE:603717 vs PWR, FIX, EME: Receivables Turnover Comparison
For the Engineering & Construction subindustry, TianYu Bio-Technology Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TianYu Bio-Technology Co Receivables Turnover vs Construction Industry
For the Construction industry and Industrials sector, TianYu Bio-Technology Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where TianYu Bio-Technology Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TianYu Bio-Technology Co (SHSE:603717) has a Receivables Turnover of 0.60 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on TianYu Bio-Technology Co and its competitors. According to the industry distribution chart, TianYu Bio-Technology Co ranks #1484 out of 1771 companies in the Construction industry, placing it in the top 83.8%.
Is TianYu Bio-Technology Co's Receivables Turnover too high?
TianYu Bio-Technology Co's current Receivables Turnover is 0.60. The Construction industry median Receivables Turnover is 4.82. TianYu Bio-Technology Co's value of 0.60 is 87.6% below this industry median. Based on the distribution chart, TianYu Bio-Technology Co ranks #1484 out of 1771 companies in the Construction industry, which is in the bottom quartile relative to peers. Overall, TianYu Bio-Technology Co has a GF Score™ of 41/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does TianYu Bio-Technology Co's Receivables Turnover compare to PWR and FIX?
According to the Construction industry distribution chart, TianYu Bio-Technology Co ranks #1484 out of 1771 companies for Receivables Turnover. This places TianYu Bio-Technology Co in the lower half of its industry. The industry median Receivables Turnover is 4.82. TianYu Bio-Technology Co's value of 0.60 is 87.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Construction company?
The median Receivables Turnover among Construction companies is 4.82, based on 1,771 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TianYu Bio-Technology Co's current Receivables Turnover of 0.60 is 87.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on TianYu Bio-Technology Co and its competitors. For the Construction industry, the median Receivables Turnover is 4.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TianYu Bio-Technology Co's current Receivables Turnover is 0.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TianYu Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, TianYu Bio-Technology Co (SHSE:603717) is currently considered Fairly Valued. The stock's GF Value™ is ¥6.00, compared to a current price of ¥6.33 — trading 5.5% above its estimated fair value. The current Receivables Turnover is 0.60 and 87.6% below the Construction industry median of 4.82. TianYu Bio-Technology Co's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For TianYu Bio-Technology Co (SHSE:603717), the current Receivables Turnover is 0.60 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TianYu Bio-Technology Co (SHSE:603717) Overvalued in 2026?
Based on GuruFocus' analysis, TianYu Bio-Technology Co stock appears to be overvalued.
The current stock price of ¥6.33 is trading 5.5% above its estimated GF Value™ of ¥6.00.
GuruFocus considers TianYu Bio-Technology Co to be Fairly Valued.
Key valuation signals for SHSE:603717:
Receivables Turnover: 0.60
GF Value™: ¥6.00 vs. price of ¥6.33 (5.5% above fair value)
Industry Position: 87.6% below the Construction median (#1484 of 1771)
No single metric tells the full story. See the SHSE:603717 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TianYu Bio-Technology Co Ltd is engaged in Garden ecological engineering business, ecological environment management and rural complex business, pig breeding business, production and marketing of agricultural products and cash crops.
41GF Score
Get the complete analysis for SHSE:603717
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603717 has been successfully added to your 
